-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Friday's Pre-Market Session
Share
Listen to the news

Gainers

  • Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 28.3% to $21.53 during Friday's pre-market session. The company's market cap stands at $27.4 million.
  • Akanda (NASDAQ:AKAN) shares increased by 16.72% to $9.42. The company's market cap stands at $4.3 million.
  • Tenet Healthcare (NYSE:THC) shares moved upwards by 14.81% to $228.5. The company's market cap stands at $17.4 billion. As per the news, the Q2 earnings report came out yesterday.
  • Pomdoctor (NASDAQ:POM) shares increased by 9.22% to $0.78. The company's market cap stands at $85.1 million.
  • SkyAI (NASDAQ:SKYA) stock rose 9.09% to $1.56. The company's market cap stands at $60.5 million.
  • Adagio Medical Holdings (NASDAQ:ADGM) shares increased by 8.91% to $0.53. The company's market cap stands at $10.8 million.

Losers

  • Radiopharm Theranostics (NASDAQ:RADX) stock declined by 45.2% to $2.35 during Friday's pre-market session.
  • Zevra Therapeutics (NASDAQ:ZVRA) shares declined by 31.91% to $8.53. The market value of their outstanding shares is at $740.1 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock fell 30.07% to $0.23. The market value of their outstanding shares is at $12.7 million.
  • Codexis (NASDAQ:CDXS) stock decreased by 25.13% to $1.49. The market value of their outstanding shares is at $180.8 million.
  • Nanoviricides (AMEX:NNVC) shares declined by 11.77% to $1.35. The market value of their outstanding shares is at $35.1 million.
  • IM Cannabis (NASDAQ:IMCC) stock decreased by 10.6% to $0.12. The company's market cap stands at $1.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending